Global Lung Cancer Surgery Market Industry: Market Size & Forecast 2026

The lung cancer surgery market covers a wide range of procedures and medical devices used in the surgical treatment of malignant lung tumors. It includes traditional open thoracotomy, video-assisted thoracoscopic surgery (VATS), robotic-assisted surgery, and the associated instruments, staplers, energy devices, and imaging systems. The market serves hospitals, ambulatory surgical centers, and specialized thoracic surgery clinics worldwide.

• •Market valued at approximately USD 5.6 billion in 2025 with a projected CAGR of around 5.9%
• •Covers lobectomy, segmentectomy, wedge resection, sleeve resection, and diagnostic mediastinoscopy procedures
• •Spans surgical instruments, energy devices, staplers, robotic systems, and intraoperative imaging technologies

Rising global incidence of lung cancer, particularly in developing economies with growing rates of tobacco use and industrial pollution exposure, is a primary driver of market expansion. Increased screening using low-dose CT scans has led to earlier detection of operable tumors, expanding the pool of candidates for surgical intervention. The shift toward minimally invasive techniques, which reduce hospital stays and complication rates, has also accelerated adoption of advanced surgical platforms.

• •Growing global prevalence of lung cancer linked to smoking, environmental pollution, and aging demographics
• •Expanded use of low-dose CT screening programs resulting in earlier-stage diagnoses suitable for surgery
• •Transition from open thoracotomy to VATS and robotic-assisted procedures improving clinical outcomes

The market is segmented by procedure type, including VATS, robotic-assisted surgery, and open surgery, with minimally invasive approaches capturing an increasing share of procedures. Key product categories encompass surgical staplers, energy devices, suturing instruments, and robotic surgical systems. Geographically, North America and Europe dominate due to advanced healthcare infrastructure, while Asia-Pacific is emerging as the fastest-growing region driven by improving medical facilities and rising disease burden.

• •Minimally invasive procedures (VATS and robotic-assisted) are the fastest-growing surgical segments
• •North America holds the largest regional share, supported by high healthcare spending and technology adoption
• •Asia-Pacific is projected to record the strongest growth due to expanding healthcare access and rising lung cancer rates

What are the recent trends and outlook?

The market is moving toward increasingly precise and less invasive surgical modalities, with robotic-assisted and image-guided techniques gaining prominence. AI-powered surgical planning tools and augmented reality navigation systems are being integrated to improve tumor localization and operative accuracy. Continued investment in healthcare infrastructure across emerging markets and ongoing clinical validation of newer surgical platforms position the market for sustained growth beyond 2030.

• •Integration of artificial intelligence and augmented reality for improved surgical navigation and precision
• •Hybrid operating rooms equipped with advanced imaging are becoming standard in leading thoracic surgery centers
• •Emerging-market hospital expansions and rising surgical device procurement are expected to widen the addressable market